Drug Shortage Report for TEVA-EZETIMIBE
Report ID | 209133 |
Drug Identification Number | 02354101 |
Brand name | TEVA-EZETIMIBE |
Common or Proper name | TEVA-EZETIMIBE 10MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | EZETIMIBE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | PP30 |
ATC code | C10AX |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-11-01 |
Estimated end date | 2024-03-20 |
Actual end date | 2024-01-24 |
Shortage status | Resolved |
Updated date | 2024-01-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-01-25 | French | Compare |
v9 | 2024-01-25 | English | Compare |
v8 | 2024-01-18 | French | Compare |
v7 | 2024-01-18 | English | Compare |
v6 | 2023-11-16 | French | Compare |
v5 | 2023-11-16 | English | Compare |
v4 | 2023-11-09 | French | Compare |
v3 | 2023-11-09 | English | Compare |
v2 | 2023-11-03 | French | Compare |
v1 | 2023-11-03 | English | Compare |
Showing 1 to 10 of 10